<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="failure. The authors draw on literature from other viral epidemics," exact="treatment" post="of acute respiratory distress syndrome, and recent publications on"/>
 <result pre="infection, the group of viruses that cause lower respiratory tract" exact="infection" post="is smaller, but includes influenza and parainfluenza, respiratory syncytial"/>
 <result pre="dependence may explain the clinical presentations of lower respiratory tract" exact="infection" post="and enteritis in COVID-19. Angiotensin converting enzyme-2 expression in"/>
 <result pre="Coronaviruses employ multiple mechanisms to shield viral RNA from host" exact="detection" post="and subsequent induction of antiviral interferon responses, including direct"/>
 <result pre="less negative selective pressure.7 The majority of patients with COVID-19" exact="infection" post="present with fever as the first symptom. Other common"/>
 <result pre="extracorporeal membrane oxygenation.17,22â€&quot;24212223 A summary of COVID-19 symptoms, complications, and" exact="treatment" post="in the initial wave of case series publications is"/>
 <result pre="effusions, or cavitation, and would potentially suggest other pathologies.28 For" exact="diagnosis" post="of SARS-CoV-2, reverse transcriptase-polymerase chain reaction testing is the"/>
 <result pre="other pathologies.28 For diagnosis of SARS-CoV-2, reverse transcriptase-polymerase chain reaction" exact="testing" post="is the standard assay. Throat swab and nasal swab"/>
 <result pre="transcriptase-polymerase chain reaction is a useful test to confirm the" exact="diagnosis" post="of COVID-19, with limitations of sample collection and kit"/>
 <result pre="to 60% at initial presentation.29 Serial reverse transcriptase-polymerase chain reaction" exact="testing" post="and inclusion of lower airway sampling can improve the"/>
 <result pre="imaging has been proposed as a primary tool for COVID-19" exact="detection" post="in hospitalized patients in epidemic areas. However, within the"/>
 <result pre="potential role for airway clearance and bronchial hygiene in the" exact="treatment" post="of COVID-19. The full ramifications of SARS-CoV-2 infection are"/>
 <result pre="in the treatment of COVID-19. The full ramifications of SARS-CoV-2" exact="infection" post="are yet to be understood. Early work points to"/>
 <result pre="rate among hospitalized patients with confirmed SARS-CoV-2, and an ARDS" exact="diagnosis" post="in 60 to 70% of patients admitted to the"/>
 <result pre="recommendations for the care of patients with COVID-19â€&quot;associated ARDS.50â€&quot;53 The" exact="treatment" post="of patients with COVID-19â€&quot;associated ARDS is made more complex"/>
 <result pre="with COVID-19â€&quot;associated ARDS is made more complex due to necessary" exact="infection" post="control interventions such as the use of isolation rooms"/>
 <result pre="to necessary infection control interventions such as the use of" exact="isolation" post="rooms and the need for care providers to wear"/>
 <result pre="SARS-CoV-2 from patients to healthcare workers has been reported, and" exact="infection" post="control is of primary importance to protect healthcare workers"/>
 <result pre="high flow nasal cannula as an initial strategy for the" exact="treatment" post="of COVID-19â€&quot;associated respiratory failure appears reasonable when patients are"/>
 <result pre="While a helmet mask may be additionally beneficial from an" exact="infection" post="control perspective, this intervention is not widely available.63 Experience"/>
 <result pre="and required invasive mechanical ventilation.64 An observational study of the" exact="treatment" post="of patients with Middle East respiratory syndromeâ€&quot;related coronavirus reported"/>
 <result pre="noninvasive positive pressure ventilation as an initial strategy for the" exact="treatment" post="of COVID-19â€&quot;associated ARDS is likely reasonable in the subset"/>
 <result pre="meta-analysis.66â€&quot;68 Experimental studies of exhaled air dispersion by mannequins in" exact="isolation" post="rooms using conventional low flow nasal cannula, high flow"/>
 <result pre="any supplemental oxygen therapy should be cared for in airborne" exact="isolation" post="rooms whenever possible, with staff using full contact, droplet,"/>
 <result pre="whenever possible, with staff using full contact, droplet, and airborne" exact="isolation" post="precautions.51,71 Providers should be aware that coronaviruses can remain"/>
 <result pre="respiratory failure develop superimposed septic shock, adherence to standard sepsis" exact="treatment" post="protocols is advised.49 Additional, nonevidence-based recommendations for the management"/>
 <result pre="Therapeutic Interventions While there are no drugs specifically approved for" exact="treatment" post="of COVID-19, there are multiple ongoing clinical trials and"/>
 <result pre="(trial Nos. NCT04252664 and NCT04257656). Remdesivir is also the initial" exact="treatment" post="arm in an adaptive clinical trial sponsored by the"/>
 <result pre="inhibit SARS-CoV-2 at micromolar concentrations. This agent, which blocks virus" exact="infection" post="both at entry and postentry stages, has been used"/>
 <result pre="evades cellular and humoral immunity, sharply limiting vaccination approaches,101 SARS-CoV" exact="infection" post="appeared to induce broad and long-lasting immunity with less"/>
 <result pre="of infection.Radiology2020: 200463DOI: 10.1148/radiol.202020046332077789 29.AiTYangZHouHZhanCChenCLvWTaoQSunZXiaLCorrelation of chest CT and RT-PCR" exact="testing" post="in coronavirus disease 2019 (COVID-19) in China: A report"/>
 <result pre="10.1056/NEJMc2001737 40.ZhaoSLingKYanHZhongLPengXYaoSHuangJChenXAnesthetic management of patients with suspected 2019 novel coronavirus" exact="infection" post="during emergency procedures.JCardiothorac Vasc Anesth2020DOI: 10.1053/j.jvca.2020.02.039 41.CrookeSNOvsyannikovaIGPolandGAKennedyRBImmunosenescence and human"/>
 <result pre="45.ChanKHChengVCWooPCLauSKPoonLLGuanYSetoWHYuenKYPeirisJSSerological responses in patients with severe acute respiratory syndrome coronavirus" exact="infection" post="and cross-reactivity with human coronaviruses 229E, OC43, and NL63.Clin"/>
 <result pre="49.collab: World Health Organiziation: Clinical management of severe acute respiratory" exact="infection" post="when novel coronavirus (nCoV) infection is suspected.Interim GuidanceUpdated January"/>
 <result pre="management of severe acute respiratory infection when novel coronavirus (nCoV)" exact="infection" post="is suspected.Interim GuidanceUpdated January 28, 2020. Available at:https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected. Accessed"/>
 <result pre="Accessed March 6, 2020. 50.JinYHCaiLChengZSChengHDengTFanYPFangCHuangDHuangLQHuangQHanYHuBHuFLiBHLiYRLiangKLinLKLuoLSMaJMaLLPengZYPanYBPanZYRenXQSunHMWangYWangYYWengHWeiCJWuDFXiaJXiongYXuHBYaoXMYuanYFYeTSZhangXCZhangYWZhangYGZhangHMZhaoYZhaoMJZiHZengXTWangYYWangXHA rapid advice guideline for the" exact="diagnosis" post="and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia"/>
 <result pre="6, 2020. 50.JinYHCaiLChengZSChengHDengTFanYPFangCHuangDHuangLQHuangQHanYHuBHuFLiBHLiYRLiangKLinLKLuoLSMaJMaLLPengZYPanYBPanZYRenXQSunHMWangYWangYYWengHWeiCJWuDFXiaJXiongYXuHBYaoXMYuanYFYeTSZhangXCZhangYWZhangYGZhangHMZhaoYZhaoMJZiHZengXTWangYYWangXHA rapid advice guideline for the diagnosis and" exact="treatment" post="of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version).Mil"/>
 <result pre="novel coronavirus pneumonia: Clinical efficacy and reduction in risk of" exact="infection" post="transmission.Chin Med J (Engl)2020DOI: 10.1097/CM9.0000000000000761 54.PengPWWongDTBevanDGardamMInfection control and anesthesia:"/>
 <result pre="One2010; 5:e1071720502660 69.HuiDSChowBKChuLNgSSLaiSTGinTChanMTExhaled air dispersion and removal is influenced by" exact="isolation" post="room size and ventilation settings during oxygen delivery via"/>
 <result pre="Res2020DOI: 10.1038/s41422-020-0282-0 88.VincentMJBergeronEBenjannetSEricksonBRRollinPEKsiazekTGSeidahNGNicholSTChloroquine is a potent inhibitor of SARS coronavirus" exact="infection" post="and spread.Virol J2005; 2:6916115318 89.ChuCMChengVCHungIFWongMMChanKHChanKSKaoRYPoonLLWongCLGuanYPeirisJSYuenKYcollab: Group HUSS: Role of"/>
 <result pre="J2005; 2:6916115318 89.ChuCMChengVCHungIFWongMMChanKHChanKSKaoRYPoonLLWongCLGuanYPeirisJSYuenKYcollab: Group HUSS: Role of lopinavir/ritonavir in the" exact="treatment" post="of SARS: Initial virological and clinical findings.Thorax2004; 59: 252â€&quot;6."/>
 <result pre="of the index patient who caused tertiary transmission of COVID-19" exact="infection" post="in Korea: The application of lopinavir/ritonavir for the treatment"/>
 <result pre="COVID-19 infection in Korea: The application of lopinavir/ritonavir for the" exact="treatment" post="of COVID-19 infected pneumonia monitored by quantitative RT-PCR.J Korean"/>
 <result pre="monitored by quantitative RT-PCR.J Korean Med Sci2020; 35:e79DOI: 10.3346/jkms.2020.35.e7932056407 91.LuHDrug" exact="treatment" post="options for the 2019-new coronavirus (2019-nCoV).Biosci Trends2020DOI: 10.5582/bst.2020.01020 92.FanZChenLLiJTianCZhangYHuangSLiuZChengJClinical"/>
 <result pre="Database Syst Rev2019; 7:CD00447731334568 96.VillarJFerrandoCMartÃ­nezDAmbrÃ³sAMuÃ±ozTSolerJAAguilarGAlbaFGonzÃ¡lez-HiguerasEConesaLAMartÃ­n-RodrÃ­guezCDÃ­az-DomÃ­nguezFJSerna-GrandePRivasRFerreresJBeldaJCapillaLTalletAAÃ±Ã³nJMFernÃ¡ndezRLGonzÃ¡lez-MartÃ­nJMcollab: Dexamethasone in ARDS Network: Dexamethasone" exact="treatment" post="for the acute respiratory distress syndrome: A multicentre, randomised"/>
 <result pre="A multicentre, randomised controlled trial.Lancet Respir Med2020; 8:267â€&quot;7632043986 97.BasarakoduKRAronowWSNairCKLakkireddyDKondurAKorlakuntaHValasareddiSLLemVSchullerDDifferences in" exact="treatment" post="and in outcomes between idiopathic and secondary forms of"/>
 <result pre="of organizing pneumonia.Am J Ther2007; 14:422â€&quot;617890928 98.RadzikowskaEWiatrELangfortRBestryISkoczylasASzczepulska-WÃ³jcikEGawrylukDRudziÅ&quot;skiPChorostowska-WynimkoJRoszkowski-ÅšliÅ¼KCryptogenic organizing pneumonia-Results of" exact="treatment" post="with clarithromycin versus corticosteroids-Observational study.PLoS One2017; 12:e018473928945804 99.WuCChenXCaiYXiaJZhouXXuSHuangHZhangLZhouXDuCZhangYSongJWangSChaoYYangZXuJZhouXChenDXiongWXuLZhouFJiangJBaiCZhengJSongYRisk factors"/>
</results>
